The diacylglycerol kinase inhibitor, R59022, potentiates cholecystokinin-induced enzyme secretion from rabbit pancreatic acini

Eur J Biochem. 1990 Mar 10;188(2):333-8. doi: 10.1111/j.1432-1033.1990.tb15408.x.

Abstract

The putative inhibitor of diacylglycerol kinase activity, 6-(2-[(4-fluorophenyl)phenylmethylene]-1-piperidinyl)-ethyl-7-meth yl-5H- thiazolo[3,2-a]pyrimidin-5-one (R59022), markedly potentiated cholecystokinin-C-terminal-octapeptide(CCK-8-)stimulated enzyme secretion from isolated rabbit pancreatic acini. Maximal potentiation occurred when acini were stimulated in the presence of 5-10 microM R59022. Potentiation depended both on the concentration of R59022 and CCK-8. No potentiation was observed when acini were half-maximally stimulated, whereas the secretory response to maximal and supramaximal concentrations of secretagogue was increased by 50-60%. R59022 alone had no effect on basal enzyme secretion and the drug did not potentiate the secretory response to the Ca2+ ionophore A23187 or to the phorbol ester, 12-O-tetradecanoylphorbol 13-acetate. Moreover, no increase in basal secretion was observed when acini were incubated in the presence of both R59022 and forskolin. These observations strongly suggest that receptor-mediated activation of the inositol phospholipid pathway is required for R59022-induced potentiation. R59022 inhibited the CCK-8-stimulated incorporation of 32Pi into phosphatidic acid dose dependently, without affecting the CCK-8-stimulated hydrolysis of 32P-labelled phosphatidylinositol 4,5-bisphosphate. This is consistent with an inhibitory effect of R59022 on acinar cell diacylglycerol kinase activity. The potentiating effect of R59022 was mimicked by 12-O-tetradecanoylphorbol 13-acetate added simultaneously with CCK-8. Therefore, it is concluded that in the presence of 5-10 microM R59022 the receptor-mediated increase in acinar cell diacylglycerol content is enhanced leading to enhanced activation of protein kinase C and to potentiation of the secretory response. The fact that the secretory response to maximal and supramaximal concentrations of CCK-8 is potentiated by R59022 suggests that at these concentrations of secretagogue the diacylglycerol/protein kinase C branch of the signal-transduction route is rate-limiting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amylases / metabolism
  • Animals
  • Calcimycin / pharmacology
  • Cholecystokinin / pharmacology*
  • Diacylglycerol Kinase
  • Diglycerides / metabolism
  • Diglycerides / physiology
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Hydrolysis
  • Pancreas / drug effects
  • Pancreas / enzymology*
  • Pancreas / metabolism
  • Phorbol Esters / pharmacology
  • Phosphatidic Acids / biosynthesis
  • Phosphotransferases / antagonists & inhibitors*
  • Protein Kinase C / metabolism*
  • Pyrimidinones / pharmacology*
  • Rabbits
  • Thiazoles / pharmacology*

Substances

  • Diglycerides
  • Phorbol Esters
  • Phosphatidic Acids
  • Pyrimidinones
  • Thiazoles
  • Calcimycin
  • Cholecystokinin
  • R 59022
  • Phosphotransferases
  • Diacylglycerol Kinase
  • Protein Kinase C
  • Amylases